PET/CT Imaging in Cancers
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 1001
Special Issue Editor
Interests: PET: evaluation of early response, EBRT dose planning, tracer development in oncology, hypoxia; targeted drug delivery: imaging applications, PET/SPECT; radionuclide therapy: personalized approaches, dosimetry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
PET/CT is becoming increasingly relevant for cancer diagnosis and assessing the response to treatment. In recent years, the role of PET/CT for the evaluation of a high number of diseases has emerged, particularly for neoplastic conditions. The unique feature of this hybrid imaging modality to combine both anatomical and functional information is fundamental for the assessment of neoplasm. Moreover, the use of different positron emitter tracers can provide knowledge about different metabolic pathways, extending the field of PET/CT application. Lastly, the rising use of radiomics in both conventional and hybrid imaging is constantly providing new diagnostic perspectives.
In this Special Issue of Diagnostics, entitled “PET/CT Imaging in Cancers”, we welcome original scientific contributions or review papers that focus on innovative clinical and preclinical approaches for the PET/CT imaging of cancers.
Prof. Dr. Kalevi Kairemo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- PET/CT
- molecular imaging
- oncology management
- cancers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
